Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

NCT05686642 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: LT3001 Drug:high dose
DRUG: Placebo
DRUG: LT3001 Drug:low dose

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd